MTOR and neoplasm: Cells and tumours containing mutations or deletions of these tumour suppressors exhibit uncontrolled mtor signalling and an increase in phosphorylation of the downstream targets Eif4Ebp1 (eukaryotic translation initiation factor 4E binding protein 1) and S6 kinase7–9.